Evidence map›Paper›PMID 33637520›Full record

ArticleScience advances2021

The use of nanovibration to discover specific and potent bioactive metabolites that stimulate osteogenic differentiation in mesenchymal stem cells.

Tom Hodgkinson, P Monica Tsimbouri, Virginia Llopis-Hernandez, Paul Campsie, David Scurr, Peter G Childs, David Phillips, Sam Donnelly, Julia A Wells, Fergal J O'Brien and 8 more

Abstract read
In one paragraph

Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. The Evolving Landscape of Potency Assays.Advances in experimental medicine and biology · 2023
    Article
  13. Identifying Biomarkers for Osteogenic Potency Assay Development.Advances in experimental medicine and biology · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Tom HodgkinsonCentre for the Cellular Microenvironment, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK.ORCID 0000-0002-3242-1593
P Monica TsimbouriCentre for the Cellular Microenvironment, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK.
Virginia Llopis-HernandezCentre for the Cellular Microenvironment, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK.ORCID 0000-0002-7616-7347
Paul CampsieSUPA Department of Biomedical Engineering, University of Strathclyde, Glasgow G1 1QE, UK.ORCID 0000-0003-4570-7133
David ScurrSchool of Pharmacy, The University of Nottingham, Nottingham NG7 2RD, UK.ORCID 0000-0003-0859-3886
Peter G ChildsCentre for the Cellular Microenvironment, Division of Biomedical Engineering, School of Engineering, University of Glasgow, Glasgow G12 8LT, UK.ORCID 0000-0001-7603-9911
David PhillipsSchool of Chemistry, College of Science and Engineering, University of Glasgow, Glasgow G12 8QQ, UK.ORCID 0000-0002-9480-5808
Sam DonnellyCentre for the Cellular Microenvironment, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK.ORCID 0000-0002-8894-0587
Julia A WellsBone and Joint Research Group, Centre for Human Development, Stem Cells and Regeneration, Institute of Developmental Sciences, University of Southampton, Southampton SO16 6YD, UK.ORCID 0000-0001-8272-0236
Fergal J O'BrienTissue Engineering Research Group, Department of Anatomy and Regenerative Medicine, Royal College of Surgeons in Ireland, Dublin D2, Ireland.ORCID 0000-0003-2030-8005
Manuel Salmeron-SanchezCentre for the Cellular Microenvironment, Division of Biomedical Engineering, School of Engineering, University of Glasgow, Glasgow G12 8LT, UK.ORCID 0000-0002-8112-2100
Karl BurgessGlasgow Polyomics, College of Medical, Veterinary and Life Sciences, University of Glasgow, Switchback Rd., Bearsden, Glasgow G61 1BD, UK.
Morgan AlexanderSchool of Pharmacy, The University of Nottingham, Nottingham NG7 2RD, UK.ORCID 0000-0001-5182-493X
Massimo VassalliCentre for the Cellular Microenvironment, Division of Biomedical Engineering, School of Engineering, University of Glasgow, Glasgow G12 8LT, UK.ORCID 0000-0002-3063-4376
Richard O C OreffoBone and Joint Research Group, Centre for Human Development, Stem Cells and Regeneration, Institute of Developmental Sciences, University of Southampton, Southampton SO16 6YD, UK.ORCID 0000-0001-5995-6726
Stuart ReidSUPA Department of Biomedical Engineering, University of Strathclyde, Glasgow G1 1QE, UK.ORCID 0000-0002-9728-3507
David J FranceSchool of Chemistry, College of Science and Engineering, University of Glasgow, Glasgow G12 8QQ, UK.ORCID 0000-0002-5409-3316
Matthew J DalbyCentre for the Cellular Microenvironment, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK. matthew.dalby@glasgow.ac.uk.ORCID 0000-0002-0528-3359

Funding

Medical Research Council MR/R015651/1
6 · The paper itself

Abstract

Bioactive metabolites have wide-ranging biological activities and are a potential source of future research and therapeutic tools. Here, we use nanovibrational stimulation to induce osteogenic differentiation of mesenchymal stem cells, in the absence of off-target, nonosteogenic differentiation. We show that this differentiation method, which does not rely on the addition of exogenous growth factors to culture media, provides an artifact-free approach to identifying bioactive metabolites that specifically and potently induce osteogenesis. We first identify a highly specific metabolite, cholesterol sulfate, an endogenous steroid. Next, a screen of other small molecules with a similar steroid scaffold identified fludrocortisone acetate with both specific and highly potent osteogenic-inducing activity. Further, we implicate cytoskeletal contractility as a measure of osteogenic potency and cell stiffness as a measure of specificity. These findings demonstrate that physical principles can be used to identify bioactive metabolites and then enable optimization of metabolite potency can be optimized by examining structure-function relationships.

Indexed as

Mesenchymal Stem CellsOsteogenesisCell Differentiation

Identifiers

PMID33637520
PMCPMC7909882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.